- Home
- GILT vs SCPH Comparison
GILT vs SCPH Comparison
Compare GILT & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILT
- SCPH
- Stock Information
- Founded
- GILT 1987
- SCPH 2013
- Country
- GILT Israel
- SCPH United States
- Employees
- GILT N/A
- SCPH N/A
- Industry
- GILT Radio And Television Broadcasting And Communications Equipment
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- GILT Technology
- SCPH Health Care
- Exchange
- GILT Nasdaq
- SCPH Nasdaq
- Market Cap
- GILT 381.2M
- SCPH 173.6M
- IPO Year
- GILT 1993
- SCPH 2017
- Fundamental
- Price
- GILT $7.38
- SCPH $4.51
- Analyst Decision
- GILT Strong Buy
- SCPH Strong Buy
- Analyst Count
- GILT 2
- SCPH 3
- Target Price
- GILT $8.50
- SCPH $14.00
- AVG Volume (30 Days)
- GILT 474.5K
- SCPH 276.4K
- Earning Date
- GILT 08-06-2025
- SCPH 08-13-2025
- Dividend Yield
- GILT N/A
- SCPH N/A
- EPS Growth
- GILT N/A
- SCPH N/A
- EPS
- GILT 0.24
- SCPH N/A
- Revenue
- GILT $321,407,000.00
- SCPH $41,982,000.00
- Revenue This Year
- GILT $42.88
- SCPH $108.95
- Revenue Next Year
- GILT $13.26
- SCPH $73.83
- P/E Ratio
- GILT $31.38
- SCPH N/A
- Revenue Growth
- GILT 13.49
- SCPH 138.10
- 52 Week Low
- GILT $4.04
- SCPH $1.94
- 52 Week High
- GILT $8.07
- SCPH $5.65
- Technical
- Relative Strength Index (RSI)
- GILT 63.94
- SCPH 60.01
- Support Level
- GILT $7.01
- SCPH $3.83
- Resistance Level
- GILT $8.07
- SCPH $4.18
- Average True Range (ATR)
- GILT 0.27
- SCPH 0.17
- MACD
- GILT 0.05
- SCPH -0.02
- Stochastic Oscillator
- GILT 58.61
- SCPH 76.60
About GILT Gilat Satellite Networks Ltd.
Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs), and Transceivers. The company's solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense, and public safety.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.